)
)
)
Solaxa Inc.
Solaxa is a clinical-stage neurology company developing a portfolio of aminopyridines, a potent class of voltage-gated ion channel blockers, to treat rare neurodegenerative diseases and acute nerve injuries resulting from chemotherapy and physical trauma. We are actively pursuing strategic collaborations, including out-licensing, co-development, and investment partnerships, to advance our programs.
Address
BethesdaMaryland
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)